Emergent Biosolutions (EBS) Com Stk USD0.001

Sell:$6.42Buy:$6.44$0.52 (7.49%)

Prices delayed by at least 15 minutes
Sell:$6.42
Buy:$6.44
Change:$0.52 (7.49%)
Deal now
Prices delayed by at least 15 minutes
Sell:$6.42
Buy:$6.44
Change:$0.52 (7.49%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.

Key people

Joseph C. Papa
President, Chief Executive Officer, Director
Richard S. Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
William Hartzel
Senior Vice President - Manufacturing and Bioservices
Paul Williams
Senior Vice President - Products Business
Simon C Lowry
Chief Medical Officer, Head of Research and Development
Zsolt Harsanyi
Independent Chairman of the Board
Sujata T. Dayal
Independent Director
Donald W. Degolyer
Independent Director
Neal Fowler
Independent Director
Keith A. Katkin
Independent Director
Click to see more

Key facts

  • EPIC
    EBS
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US29089Q1058
  • Market cap
    $365.29m
  • Employees
    900
  • Shares in issue
    59.88m
  • Exchange
    New York Stock Exchange
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.